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Thirty-year-old female with a previous history of a cutaneous ulcer suspicious of leishmaniasis 20 years ago presented with a new
complaint of a depressed papular lesion 8 × 7mm in the right lower extremity. The lesion was of 10-day duration. Because early
cutaneous leishmaniasis (CL) lesions may have a non-ulcerated appearance, a Leishmania skin test (LST) was performed on the
forearmwithastrongpositiveresult(38×32mm).After8days,thelesionintheleg,whichwasdiagnosedasfolliculitis,completely
healed. However, a typical CL ulcer (26 × 24mm) developed at the LST site. Histopathology of the new lesion did not identiﬁy
parasites, but the ﬁndings were consistent with a diagnosis of CL. Further analysis identiﬁed amastigotes by immunohistochemical
stain.MononuclearcellsharvestedfromthepatientwerestimulatedwithLeishmaniaantigenandshowedhighlevelsofproduction
o fb o t ht u m o rn e c r o s i sf a c t o r - a l p h a(T N F - α) and interferon-gamma (IFN-γ): 2,943pg/mL and 2,313pg/mL, respectively. After 40
days of treatment with antimony and pentoxifylline, the ulcer resolved. The development of CL at the LST site suggests a strong
Th1 immune response, and it is an in vivo documentation of the role of the host immune response in the pathology of CL. It
teaches us that LST should be cautiously, if at all, used in patients with self-healing CL ulcers.
1.Introduction
Cutaneous leishmaniasis (CL) due to Leishmania brazilien-
sis is characterized by a well-delimited ulcer with raised
borders and localized mainly on the inferior limbs [1, 2].
In CL, parasites are not easily found in the lesion. The
sensitivity of serological tests is low. However, the predictive
value of the delayed-type hypersensitivity Leishmania skin
t e s t( L S T )i sh i g h[ 3, 4]. Thus, when parasites are not
detected, a positive LST accompanied by typical ulcer and
histopathological ﬁndings compatible with leishmaniasis is
accepted as diagnostic standard for CL in endemic areas
[3]. The test is considered safe, and its side eﬀects are mild
[4]. Rarely topical steroids are needed to attenuate pain,
erythema, or eruptive lesions that appear after the test is
administered. Both parasite and host immunological factors
participate in the pathogenesis of CL. Although the ability to
mountatype1immuneresponsetoLeishmaniaisassociated
with protection [5], in L. braziliensis infection, the tissue
damage is associated with an exaggerated cell-mediated
immuneresponse[6,7].Thiscaserepresentsinvivoevidence
of the host immune response in the pathogenesis of CL
ulcers.
2. Case Presentation
RJS, a 30-year-old woman, was seen at the health post of
Corte de Pedra, Tancredo Neves—Bahia, a reference center
fordiagnosisandtreatmentofCL.Thepatientcomplainedof
a small papular lesion in her right leg developing over seven
to 10 days. When she was 10 years of age, she had an ulcer in
the left thigh suspicious of CL that spontaneously healed in
about 4 months. Given her prior history of ulcer, she decided
to seek help at the health post when the new lesion appeared.2 Case Reports in Medicine
Figure 1: A well-delimited atrophic scar in the left thigh measuring
30 ×20mm.
On physical examination, a depressed papular lesion mea-
suring 8 × 7mm in the right leg suspicious of folliculitis
was noted. There was also a well-deﬁned atrophic scar in the
left thigh, measuring 30 × 20mm (Figure 1). There was no
lymphadenopathy. Because early CL lesions in L. braziliensis
infection may have a papular and nonulcerated aspect [8]
and the patient lived in an endemic area, the diagnosis
o fC Lw a ss u s p e c t e d .L S Tw a sp r e p a r e da sp r e v i o u s l y
described [9]. Brieﬂy promastigotes of L. amazonensis were
disrupted initially by multiple freeze and thaw and later
by sonication. The material was adjusted to 250μg/mL
with sterile PBS containing Tween 80 and phenol [9]. An
intradermal injection of 0.1mL was administered in her
left forearm. After 48 hours, the intradermal reaction was
highly positive with an induration of 38 × 32mm. Eight
days after the skin test, while the folliculitis in the right leg
disappeared, a cutaneous round ulcer with raised borders
measuring26×24mm,typicalofleishmaniasis,wasobserved
in the site where the LST was administered (Figure 2).
The clinical picture was typical of an ulcerated CL lesion,
but the culture of the aspirated material from this lesion
was negative for Leishmania. The histopathological analysis
(Figure 3) showed chronic perivascular inﬂammation with
granuloma formation and the presence of neutrophils,
lymphocyte, monocyte, and plasma cells. Parasites were not
identiﬁed, but a few amastigote forms were detected by
immunohistochemical analysis performed with rabbit anti-
Leishmania braziliensis antibody in skin sections.
Determination of cytokine production was performed
by ELISA (R&D Systems, Minneapolis, Minn, USA) in
supernatants of peripheral blood mononuclear cells stimu-
lated with soluble Leishmania antigen (SLA) for 72 hours
[6]. TNF-α and IFN-γ levels were 47pg/mL and 0pg/mL,
Figure 2: Cutaneous round ulcer with raised borders measuring
26 × 24mm in the forearm where the Montenegro skin test was
performed.
respectively, in unstimulated cultures and were 2,943pg/mL
and 2,313pg/mL, respectively, in SLA-stimulated cultures.
These values were similar to those detected in 3 patients
with CL who were evaluated on the same day: TNF-α:
2,139±953.8; IFN-γ: 3,653±312.6. The patient was treated
with pentavalent antimony (Glucantime) in a dosage of
20mg/kg/day and pentoxifylline 400mg tid for 20 days. Pen-
toxifylline has anti-inﬂammatory properties, and it has been
previously shown that its use in combination with antimony
is more eﬀective than antimony alone in the treatment of
tegumentary leishmaniasis [10, 11]. The ulcerated lesion in
the left forearm was completely healed 40 days after the
initiation of therapy (Figure 4).
3. Discussion
This paper calls attention to a patient who had a past (20
years prior) self-healing ulcerated lesion compatible with CL
and who developed a typical ulcer of CL in the place where
a LST was performed. Although parasites were found in the
immunohistochemical analysis, there are strong indications
that the cutaneous ulcer observed in this patient was due
predominantly to the skin test with Leishmania antigen:
(1) despite that parasites DNA are found in the scar of
patients cured of tegumentary leishmaniasis, reactivation is
uncommon except in patients with HIV [12]; (2) the devel-
opment of cutaneous ulcer caused by L. braziliensis usually
takes 1-2 months and it is preceded by lymphadenopathy,
papular or nodular lesion, and a superﬁcial ulcer, features
not observed in this patient [8, 13]; (3) the lesion occurred
in the same place where the skin test was performed; (4)
while classical CL ulcers heal after 60 or 90 days of antimony
therapy [13], the cutaneous ulcer presented here healed
in less than 40 days. Together, these data suggest that CL
developed in this patient was due to a skin test performed
in the location.
Host and parasite factors participate in the pathogene-
sis of tegumentary leishmaniasis [2, 6, 7]. The persistence
of the parasites in patients with self-healing CL is impor-
tant to maintain the T cell response after clinical cure.Case Reports in Medicine 3
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Figure 3: Hematoxylin-eosin staining of biopsy. (a) Edema and chronic inﬂammation in the papillary dermis (10x). (b) Granuloma in the
dermis (10x). (c) Immunohistochemistry staining of L. braziliensis amastigotes ((100x) arrow).
It is interesting that, in this case, amastigotes were found
in a place where the LST was performed. Prior studies
have shown parasite DNA in scars of CL patients [14], but
herein we found amastigotes in the tissue where the new
ulcer developed. These parasite forms were not present in
the LST because it was prepared with promastigotes, and
as previously described it contains only SLA [9]. Moreover,
there is strong evidence for the role of T cell responses in
the pathogenesis of L. braziliensis infection including (1) a
strong inﬂammatory reaction in tissue in the absence or
with very few parasites in the lesion [15]; (2) a correlation
between frequency of CD4+ T cells expressing IFN-γ and
TNF-α and size of the lesion [7]; (3) a correlation between
CD4+ T cell activation markers expression and size of the
lesion[7];(4)presenceofcytotoxicityinpreulcerativelesions
[16]; (5) a correlation between granzyme expression by CD8
T cells and the inﬂammatory reaction in the tissue [17]; (6)
development of ulcers despite antimony therapy in patients
diagnosed with early and preulcerative CL [8, 13].
Inthepresentcase,thepatienthadahistoryofaprevious
ulcer that self-healed. Self-healing of CL usually occurs after
6 months of the initiation of the ulcer [18]. Immunological
studies in patients with self-healing CL showed that there
are a high lymphocyte proliferation and high production of
IFN-γ in cultures stimulated with SLA [18]. The presence
of a strong type 1 immune response in subjects with self-
healing disease is probably due to the presence of the parasite
and the persistent stimulation of the immune response. The
immune response in the young lady presented in this paper
was similar to that observed in patients with active CL,
despite the fact that her leishmaniasis lesion had occurred
20 years previously. In such case, the development of a
typicalCLulceraftertheintradermalinjectionofLeishmania
antigen could be explained by the activation of antigen-
reactive T cells that, after challenge, induced tissue damage at
the site the antigen was inoculated. The patient was treated
with antimony plus pentoxifylline, a TNF-α inhibitor in
part because of the previous observation that combination
therapy was more eﬀective [10, 11] and also because we
believe that the inﬂammatory response played an important
role in the development of the ulcer at the site where LST
was applied. It is known that TNF-α plays a key role in
controlling parasite multiplication in the initial phase of
Figure 4: Scar in the forearm 40 days after the initiation of therapy.
Leishmania infection [19], but it is also associated with ulcer
development [6, 7]. Therefore, it is possible that modulation
of the immune response by pentoxifylline improved the
therapeutic response in this patient [10, 11].
This paper emphasizes the role of the immune response
as a cause of the tissue damage in CL. Moreover it illustrates
important clinical lessons: ﬁrst, that antimony therapy
should be provided even for patients who present with self-
healing CL secondary to L. braziliensis infection; second, that
theLSTshouldbeusedwithcaution,ifatall,inpatientswith
self-healing CL.
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